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Abstract
Background: Reduced total brain volume is a consistent finding in children with Attention Deficit/Hyperactivity Disorder
(ADHD). In order to get a better understanding of the neurobiology of ADHD, we take the first step in studying the
dimensionality of current self-reported adult ADHD symptoms, by looking at its relation with total brain volume.
Methodology/Principal Findings: In a sample of 652 highly educated adults, the association between total brain volume,
assessed with magnetic resonance imaging, and current number of self-reported ADHD symptoms was studied. The results
showed an association between these self-reported ADHD symptoms and total brain volume. Post-hoc analysis revealed
that the symptom domain of inattention had the strongest association with total brain volume. In addition, the threshold
for impairment coincides with the threshold for brain volume reduction.
Conclusions/Significance: This finding improves our understanding of the biological substrates of self-reported ADHD
symptoms, and suggests total brain volume as a target intermediate phenotype for future gene-finding in ADHD.
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Introduction
Attention Deficit/Hyperactivity Disorder (ADHD) affects 1–4%
of adults and has an even higher prevalence in children [1].
Structural magnetic resonance imaging (MRI) studies in children
with ADHD have found reductions of around 3% in total brain
volume [2] as well as in specific (sub-) cortical brain regions [3].
Brain volumetry studies in adult ADHD patients mainly reported
reductions of brain volume in the prefrontal cortex [4,5], caudate
nucleus [6,7] and amygdala [8], as well as a marginal increase of
nucleus accumbens volume [4]. Only some of these findings have
been replicated to date [7,9].
Currently, ADHD is thought to be the extreme of a continuum of
behavior in the population [10]. This was illustrated, for example, by
work of Lubke et al, in which attention problems in children vary
along a severity continuum from mild to severe; children with
ADHD were at the extreme of the continuum [11]. Further evidence
for dimensionality can be found in studies in which neurobiological
characteristics associated with ADHD show evidence for dimen-
sionality. The study of Shaw et al showed the reduced cortical
thinning with increasing ADHD severity [12]. However these studies
concern childhood ADHD, dimensionality of ADHD symptoms in
adulthood has not been investigated in this regard.
In order to get a better understanding of the neurobiology of
ADHD, we take the first step in studying the dimensionality of
current adult ADHD symptoms, by investigating the association
between a biological construct of ADHD, brain volume, and
current self-reported ADHD symptoms in an adult population. In
addition, ADHD is a highly heritable disorder [13] yet gene-
finding approaches have been relatively unsuccessful in ADHD to
date [14] potentially due to its diagnostic/phenotypic and genetic
complexity, and given the high heritability of brain structure [15],
this study might aid in characterizing total brain volume as a target
intermediate phenotype to improve gene-finding.
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Materials and Methods
Participants
In this study, 652 subjects aged 18–35 years from the Brain
Imaging Genetics (BIG) study at the Donders Institute for Brain,
Cognition and Behavior of the Radboud University Nijmegen
Medical Centre were included. The BIG study is a study of self-
reported healthy individuals included into earlier imaging studies
at the Donders Centre for Cognitive Neuroimaging. Structural
imaging data of these studies were pooled for which subjects had to
give their consent. About 80% of the subjects have their consent to
include their structural imaging data. Subjects were of European
Caucasian descent and generally highly educated (more informa-
tion on inclusion of subjects see [16]). The study was approved by
the medical ethical committee (CMO regio Arnhem/Nijmegen)
and all participants provided written informed consent prior to
participation.
Behavioral measures
Assessment of ADHD symptoms was performed through
internet-based testing, as part of an electronic questionnaire and
test battery. Subjects were asked to complete the ADHD DSM-IV-
TR Rating Scale for current symptoms in adults [17]. Symptoms
were reported over the last 6 months. Participants had to answer
23 questions on a 4-point scale (never, sometimes, often, very
often). The 23 current item scores were recalculated to the original
18 DSM-IV-TR ADHD criteria. There are 5 symptoms that are
scored based on two items in the questionnaire because these
symptoms contain double statements in the DSM-IV-TR criteria.
For example, the symptom ‘often fails to give close attention to
details or makes careless mistakes in schoolwork, work or other
activities’, is referred to in the questionnaire by two questions ‘fail
to give close attention to details in work’ and ‘make careless
mistakes in work’. The 18 ADHD criteria consist of 9 symptoms
related to the inattentive (IA) symptom domain and 9 symptoms to
the hyperactive/impulsive (HI) symptom domain. A symptom was
considered to be present whenever the answer ‘often’ or ‘very
often’ was given. In this way, the variables IA-symptoms (range 0–
9), HI-symptoms (range 0–9) and total ADHD symptoms (range
0–18) were derived.
Imaging
Subjects were scanned at 1.5 Tesla (n = 302) and 3 Tesla
(n = 350) MRI scanners and T1-weighted structural magnetic
resonance imaging data (3D MPRAGE) were acquired (more
information on the image acquisition can be found in Text S1). All
scans covered the entire brain and had a voxel-size of
16161 mm3. To calculate total brain volume, raw DICOM
MR imaging data were converted to NIFTI format using the
conversion as implemented in SPM5 (http://www.fil.ion.ucl.ac.
uk/spm/software/spm5/). Normalizing, bias-correcting, and seg-
menting into gray matter, white matter, and cerebrospinal fluid
was performed using the VBM toolbox (VBM5.1 Toolbox version
1.19) in SPM using priors (default settings). This method uses an
optimized VBM protocol [18,19] as well as a model based on
Hidden Markov Random Fields (HMRF) developed to increase
signal-to-noise ratio [20]. Total volume of gray matter, white
matter, and cerebrospinal fluid was calculated by adding the
resulting tissue probabilities. Total brain volume was defined as
the sum of white matter and gray matter volume.
Statistical analysis
The relation between self-reported ADHD symptoms and total
brain volume was studied using linear regression analysis adjusting
for age, gender and MRI field strength (1.5T or 3T). In order to
explore effects of the distinct ADHD symptom domains on total
brain volume, a similar analysis was performed including either
Hyperactivity/Impulsivity (HI) symptom count or Inattentive (IA)
symptom count as an independent variable. Permutation tests
were performed to overcome multiple testing problems (see Text
S1). As a downstream analysis, the association between ADHD
symptom count and gray matter volume (correcting for white
matter volume) and white matter volume (correction for gray
matter volume) were performed.
In addition, we tested whether total brain volume of subjects
with 6 or more self-reported ADHD symptoms in either one
symptom domain or 6 or more symptoms in both domains (the
equivalent of the cut-off for an ADHD diagnosis according to the
DSM-IV-TR), differed from that of subjects with 4–5 self-reported
ADHD (IA and/or HI) symptoms (4 being the threshold for
increased impairment [17]) and/or subjects with 3 or less self-
reported ADHD symptoms (IA and/or HI). Linear regression
analysis was performed to assess the effect of this stratification on
total brain volume, including age, gender and field strength as
covariates. Individual groups were compared in post-hoc analyses.
Finally, voxel-based morphometry (VBM) was performed to assess
potential localized differences between these groups (for details see
Text S1).
Results
The demographics of the participants are displayed in Table 1.
Overall, 37 subjects (5.6%) reported 6 or more current HI- or IA-
symptoms in our study, where 6 would be the threshold for a
DSM-IV-TR diagnosis of ADHD (for frequency tables of the
ADHD symptom counts see Figure S1).
Association of Total Brain Volume and ADHD symptoms
The total number of self-reported ADHD symptoms was
significantly associated with total brain volume (b=2.08, nominal
p = .007, experimental p = .014). The regression coefficients of the
total number of self-reported ADHD symptoms were similar in the
two independent samples scanned at different MRI field strengths
(1.5T: b=2.07; 3T: b=2.09). Brain volume decreased with an
increasing number of self-reported ADHD symptoms (Figure 1a).
Total brain volume variation was mainly explained by IA-
symptoms (b=2.09, pnominal = .007, pempirical = .013), rather than
by HI- symptoms (b=2.06, pnominal = .064, pemperical = .123)
(Figure 1b and 1c). The association was not explained by
education level (p = .26). Neither total gray or white matter
volume were associated with the number of self-reported ADHD
symptoms (gray matter b=2.002, pnominal = .92, pemperical = .10,
white matter b=2.04, pnominal = .05, pemperical = .99).
Table 1. Demographics of the study sample (n = 652).
Age (mean ± SD; range) 22.563.2 years (range 18–35)
Male 38.0%
Education
High school degree 17.1%
Bachelor student 12.8%
Master or PhD student 70.1%
ADHD symptoms (mean ± SD) 2.862.7
Subjects were healthy individuals based on self-report.
doi:10.1371/journal.pone.0031273.t001
Total Brain Volume and ADHD Symptoms
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Grouping of individuals based on DSM-IV-TR criteria ($6 self-
reported symptoms, n = 37 more details in Figure S1) and known
impairment threshold (4–5 self-reported symptoms, n = 82) [17]
and comparing them to subjects with #3 self-reported symptoms
(n = 533) showed significant differences between groups (p = .008
and p = .04, respectively), indicating that the threshold for brain
volume reduction coincides with the threshold for functional
impairment in patients (Figure 1d).
There were no significant differences in the local gray or white
matter volumes assessed by the VBM analysis (both p(clus-
ter).0.05, data not shown) in our large sample. Indicating that
brain volume was globally affected.
Discussion
This study shows (a) that current ADHD symptoms in healthy
adults, assessed by self-report as a continuum in the population
and therefore largely independent of disease or treatment, has a
neurobiological substrate; reduced total brain volume, (b) that this
substrate is global rather than localized in the brain, and (c) that
the threshold for impairment coincides with the threshold for
brain volume reduction in patients.
The results of this study match the results of a previous study in
healthy children and adolescents showing cortical thinning, not
corrected for total brain volume, to be associated with symptoms
of ADHD [12], and therefore supporting a dimensional aspect of
biological substrates of ADHD.
Total brain volume reductions were global rather than localized
in the brain. This suggests general mechanisms affecting brain
development in neuron number, number of neurites and/or
neuronal connections. This is also consistent with hypotheses
based on findings from genome-wide association studies in ADHD
implicating neuronal migration and neurite outgrowth in disease
etiology [14,21].
This study shows that self-reported inattention symptoms are
the main predictor of total brain volume reductions. This could be
explained by the known association between inattention and
processing speed [22] and associations between the latter and
brain volume reductions [23]. However, this study was not
designed to study causative effects of brain volume reductions.
Therefore, future studies with a better suited design would be
necessary to provide additional information.
While this is the largest study of its kind and also the first to
show neurobiological dimensionality of self-reported ADHD
symptoms in an adult population, it also has a number of
limitations. Firstly, we used a self-report measure of adult ADHD
symptoms. Self-report measures are likely to be less accurate than
interviews, but for the ADHD rating scale we know from research
in patients that it has a substantial correlation with diagnostic
assessment by a clinician [24]. A second potential limitation is the
Figure 1. Distribution of total brain volume (TBV) and adult self-reported ADHD symptoms in a healthy sample (n=652). (a) TBV is
associated with the total number of self-reported ADHD symptoms. Of the two ADHD symptom domains, mainly the attentive domain contributes to
TBV: (b) inattentive symptoms (b=2.09, pnominal = .007, pempirical = .013), and (c) hyperactive/impulsive symptoms (b=2.06, pnominal = .064,
pemperical = .123). (d) Total brain volume across groups based on the number of self-reported ADHD symptoms. The group with 3 or less self-reported
symptoms differed from the intermediate group and from the group with a number of ADHD symptoms corresponding to the ADHD diagnosis ($6
in either of the two domains). *Total brain volume was adjusted for age, gender and field strength.
doi:10.1371/journal.pone.0031273.g001
Total Brain Volume and ADHD Symptoms
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unavailability of other psychiatric symptom ratings to look at the
specificity of our results. Although this was not our prime
objective, it would be very informative to find out if symptoms
of other psychiatric disorders are also associated with total brain
volume or whether this association is specific for ADHD
symptoms. Based on the study findings, suggesting a stronger role
for inattentive symptoms one might hypothesize that depression
and other disorders featuring such symptoms might also affect
brain size. Thirdly, intelligence might be an important factor for
total brain volume studies, since some studies have found
moderate correlations between intelligence and total brain volume
[25]. In the current study, direct intelligence measures were
unavailable, but we used education level as a proxy. Education did
not significantly contribute to the association between total brain
volume and self-reported ADHD symptoms in this study. In
addition, our entire sample is highly educated (mainly university
students), which probably results in low variance in IQ measures.
It is therefore not likely that IQ measures would change our
findings.
Finding genes for ADHD has been proven difficult, our
findings, in combination with those of previous studies showing
brain volume to be heritable [15], indicate that total brain volume
may be a target intermediate phenotype for future genetics studies
directed at the identification of yet unknown ADHD risk genes.
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